DOJ's Pharmacist Scapegoat: Prescribing Blame, Not Solutions
📰 THE STORY: Mainstream media reports highlight the Department of Justice's vigorous prosecution of pharmacists, depicting them as key culprits in the opioid crisis, diverting blame from pharmaceutical manufacturers and distributors, many of whom have settled with minimal repercussions for their role in flooding communities with highly addictive painkillers. 🔍 WHAT THEY'RE NOT TELLING YOU:
Historical Context: While pharmacists are being prosecuted, the true architects, Purdue Pharma, pleaded guilty in 2007 to misbranding OxyContin, paying $634 million, then again in 2020, paying $8.3 billion. The Sackler family, owners of Purdue, extracted over $10 billion from the company. The crisis didn't start with pharmacy counters; it started in boardrooms and with aggressive, deceptive
marketing of opioids, often with direct payments to doctors and academic institutions to push these drugs as safe and effective for chronic pain. Double Standard: The media and DOJ frame pharmacists, often small business owners, as criminal enterprises. Meanwhile, executives at major pharmaceutical companies like Insys Therapeutics (which paid $225 million in 2019 for bribing doctors to prescribe
fentanyl) receive comparatively lenient sentences or walk free after causing far more systemic damage. The "war on drugs" selectively targets those at the bottom of the supply chain, while the corporate magnates who engineered the addiction boom are given a slap on the wrist. Think of it as prosecuting the corner store for selling cigs while tobacco giants lobby for tax breaks. Follow the Money: